HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response of a rodent fibrosarcoma to photodynamic therapy using 5-aminolaevulinic acid or polyhaematoporphyrin.

Abstract
The effects of 5-aminolaevulinic acid (ALA)-based photodynamic therapy (PDT) on the growth of an intradermal rat fibrosarcoma have been determined following topical, intravenous, or intratumour application of ALA. The pattern of tumour growth was identical following each type of therapy and we conclude that the efficacy of ALA-PDT is independent of the route of drug administration, at least in this tumour system. We have also compared the efficacy of interstitial ALA-based PDT with similar therapy using a conventional photosensitizer, polyhaematoporphyrin (PHP). ALA-PDT was less effective than PHP-based therapy at inhibiting the growth of a subcutaneous rat fibrosarcoma at light doses over 300 J. It is suggested that protoporphyrin IX photo-bleaching may limit the effectiveness of treatment, whilst the more bleach-resistant PHP may continue to be effective at higher light doses.
AuthorsF Cairnduff, D J Roberts, B Dixon, S B Brown
JournalInternational journal of radiation biology (Int J Radiat Biol) Vol. 67 Issue 1 Pg. 93-9 (Jan 1995) ISSN: 0955-3002 [Print] England
PMID7852822 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hematoporphyrins
  • Radiation-Sensitizing Agents
  • Aminolevulinic Acid
Topics
  • Aminolevulinic Acid (therapeutic use)
  • Animals
  • Cell Division (drug effects)
  • Dose-Response Relationship, Radiation
  • Fibrosarcoma (drug therapy, pathology)
  • Hematoporphyrins (therapeutic use)
  • Light
  • Male
  • Photochemotherapy
  • Radiation-Sensitizing Agents (therapeutic use)
  • Rats
  • Rats, Inbred Strains
  • Skin Neoplasms (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: